AmVac
Zug, Zug, Switzerland
About AmVac
AmVac is a biopharmaceutical company that has prioritized the development and marketing of innovative immunological treatments and prophylactic vaccines. AmVac specializes in creating innovative therapies for respiratory, urological, and gynecological conditions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $2.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2010)
- Website: amvac.eu
- Phone: +41 417253233
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amvac-2533952 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.